Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Advanced Search
Wizards and Analytics Search
Simple Search
By Subject Area
Sales and Marketing > New Product Development and Launch > Creating Infrastructure Support > Resource Allocation
Resource Allocation Research

Resource Allocation and Launch Readiness Factors that Shape a Strong Oncology Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions 
Non-members: Click here to review a complimentary excerpt from "Resource Allocation and Launch Readiness Factors that Shape a Strong Oncology Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions" STUDY OVERVIEW One of the more difficult aspects of planning a new oncology product launch is balancing the different resource and investment allocations that are needed to prepare the marketplace for a new product... (ID 5158)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1666.00   Free Excerpt Available
Resource Allocation and Launch Readiness Factors that Shape a Strong Metabolic Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions 
Non-members: Click here to review a complimentary excerpt from "Resource Allocation and Launch Readiness Factors that Shape a Strong Metabolic Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions" STUDY OVERVIEW One of the more difficult aspects of planning a new metabolic product launch is balancing the different resource and investment allocations that are needed to prepare the marketplace for a new product... (ID 5140)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1394.00   Free Excerpt Available
Resource Allocation and Launch Readiness Factors that Shape a Strong Cardiovascular Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions 
Non-members: Click here to review a complimentary excerpt from "Resource Allocation and Launch Readiness Factors that Shape a Strong Cardiovascular Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions" STUDY OVERVIEW One of the more difficult aspects of planning a new cardiovascular product launch is balancing the different resource and investment allocations that are needed to prepare the marketplace for a new product... (ID 5131)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1632.00   Free Excerpt Available
Winning in the U.S. Marketplace: Pre-launch and Launch Activity Investment Benchmarks for New Products 
Non-members: Click here to review a complimentary excerpt from "Winning in the U... (ID 5123)
Companies Profiled: Abbott Laboratories, ProStrakan, Amylin, Astellas, more ...
Price: $4150.00   Free Excerpt Available
Winning in the U.S. Marketplace: Pre-launch and Launch Investment Benchmarks for New Products 
Non-members: Click here to review a complimentary excerpt from "Winning in the U... (ID 5122)
Companies Profiled: Abbott Laboratories, ProStrakan, Amylin, Astellas, more ...
Price: $4000.00   Free Excerpt Available
Marketing to Multicultural Physicians 
This 18-page document, based on in-depth interviews with six leading pharmaceutical companies, investigates how top pharma companies market to and build relationships with U... (ID 4425)
Companies Profiled: Sanofi-aventis, Wyeth, Roche, Pfizer, more ...
Price: $824.95
Align Marketing Staff Background and Experience with Corporate Goals in the Recruiting and Training Processes -- Part 2 
Minimize additional staffing costs by hiring consumer marketing personnel from within the organization... (ID 3658)
Companies Profiled: A Leading Pharmaceutical Company
Price: $9.95
Invest Resources for Maximum Impact -- Part 3 
Focus development resources to build expertise in strategic areas. One benchmark partner keeps two major targets in mind when choosing and refining new drugs... (ID 3617)
Companies Profiled: A Leading Pharmaceutical Company
Price: $22.95
Invest Resources for Maximum Impact -- Part 2 
Employ situation modeling and marketing counsel to determine course of the product after Phase II... (ID 3616)
Companies Profiled: A Leading Pharmaceutical Company
Price: $22.95
Invest Resources for Maximum Impact -- Part 1 
Continuously refine sales forecasting tools to optimize marketing resource allocation... (ID 3615)
Companies Profiled: A Leading Pharmaceutical Company
Price: $22.95

 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.